Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1975-02-12
1977-01-25
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31505
Patent
active
040052036
ABSTRACT:
Method and pharmaceutical preparations for treating meningeal leukemia, CNS Iymphoma and neoplasma in the brain which comprises treating an infected mammal such as a human with a dose of an effective treatment amount of a compound of Formula I ##STR1## where R is a straight or branched chain lower alkyl of 1 to 4 carbon atoms, and X is a halogen atom (fluorine, chlorine, bromine or iodine) and pharmaceutically acceptable salts thereof.
Preferred compounds for treatment of the aforementioned diseases are 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-ethylpyrimidine.
REFERENCES:
murphy et al-J. Clin. Invest. vol. 33 (1954) p. 1388 et seq.
Geils et al. Blood vol. 38 No. 2 (1971) pp. 131-137.
Elion Gertrude B.
Hitchings George H.
Nichol Charles A.
Simmons William S.
Stickney Dwight R.
Brown Donald
Burroughs Wellcome Co.
Rosen Sam
LandOfFree
Treatment of meningeal leukemia with diamino dichlorophenyl pyri does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of meningeal leukemia with diamino dichlorophenyl pyri, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of meningeal leukemia with diamino dichlorophenyl pyri will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479147